GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Hisoar Pharmaceutical Co Ltd (SZSE:002099) » Definitions » Retained Earnings

Zhejiang Hisoar Pharmaceutical Co (SZSE:002099) Retained Earnings : ¥484 Mil (As of Mar. 2025)


View and export this data going back to 2006. Start your Free Trial

What is Zhejiang Hisoar Pharmaceutical Co Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Zhejiang Hisoar Pharmaceutical Co's retained earnings for the quarter that ended in Mar. 2025 was ¥484 Mil.

Zhejiang Hisoar Pharmaceutical Co's quarterly retained earnings declined from Sep. 2024 (¥828 Mil) to Dec. 2024 (¥475 Mil) but then increased from Dec. 2024 (¥475 Mil) to Mar. 2025 (¥484 Mil).

Zhejiang Hisoar Pharmaceutical Co's annual retained earnings declined from Dec. 2022 (¥1,330 Mil) to Dec. 2023 (¥817 Mil) and declined from Dec. 2023 (¥817 Mil) to Dec. 2024 (¥475 Mil).


Zhejiang Hisoar Pharmaceutical Co Retained Earnings Historical Data

The historical data trend for Zhejiang Hisoar Pharmaceutical Co's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Hisoar Pharmaceutical Co Retained Earnings Chart

Zhejiang Hisoar Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,362.90 1,410.82 1,329.62 816.50 475.21

Zhejiang Hisoar Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 849.09 854.60 828.48 475.21 484.44

Zhejiang Hisoar Pharmaceutical Co Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


Zhejiang Hisoar Pharmaceutical Co  (SZSE:002099) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Zhejiang Hisoar Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 507 Shifu Avenue, Taizhou International Business Plaza, Block A, 8F, Taizhou, Zhejiang, CHN, 318000
Zhejiang Hisoar Pharmaceutical Co Ltd is a China-based company engages in the production of specialty raw materials, preparations and fine chemicals, dyes and dye intermediates. Its products include Clindamycin hydrochloride, Clindamycin phosphate, Florfenicol, Atova, Thiamphenicol, and Riglinay.
Executives
Wang Yang Chao Director
Yang Si Wei Directors, executives
Xu Guo Rui Executives
Xu Hua Qing Secretary Dong
Hong Ming Director
Guo Min Long Director
Li Hong Ming Executives
Jiang Ru Dong Securities Affairs Representative
Mao Wen Hua Executives
Sun Yang Director
Li Wei Jin Director
Luo Yu Hong Director
Pan Qing Hua Directors, executives
Chen Zheng Hua Supervisors
Jia Qiang Executives, directors

Zhejiang Hisoar Pharmaceutical Co Headlines

No Headlines